retatrutide or semaglutide vs. Ozempic: The Triple Agonist That May Change Everything., hits one receptor. Retatrutide hits The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

Eligible patients had to have a BMI greater than or equal to 27 kg/m 2 and less than or equal to 45 kg/m 2 (there was no lower limit on BMI for patients with type 2 diabetes mellitus) and two or more of the following obesity-related co-morbid conditions: Patients ranged in age from 19 to71 years of age (mean age 51) and 70% were female

Unlike many online programs, patients are not left to manage side effects, dose changes, or long-term treatment decisions alone

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) provide effective reductions in HbA 1c and body weight

In turn, this may change how effective the drug is in treating your condition